Two Main Cancer Biomarkers as Molecular Targets of Binase Antitumor Activity

Authors:

Elena Dudkina, Vera Ulyanova, Violetta Asmandiyarova, Valentina Vershinina, Olga Ilinskaya

Keywords:

cancer, MAPK signaling, EGFR, RAS, oncogene, ribonuclease, binase

Abstract:

Cancer is frequently coupled with the disturbance of key signaling pathways. Aberrant activation of the mitogen-activated protein kinase (MAPK) signaling cascade, occurring in over 85% of cancers, is mainly caused by the genetic alterations of its main components—oncogenes EGFR and RAS, and plays a crucial role in cell fate. The importance of EGFR and RAS proteins in a variety of tumors suggests that they would be good therapeutic targets, but at present, no effective targeted therapy against these two oncogenes has been proven. Here, we show that ribonuclease from Bacillus pumilus (binase) inhibits MAPK signaling through direct interaction with EGFR and RAS proteins. This effect contributes to the antitumor potential of binase along with its enzymatic activity. Multitargeticity of binase prevents the development of drug resistance, which is considered a major obstacle to effective anticancer treatment.

< Back to publications

Full article >